119 related articles for article (PubMed ID: 17369192)
41. TCF1 deficiency ameliorates autoimmune lymphoproliferative syndrome (ALPS)-like phenotypes of lpr/lpr mice.
Xu X; Yu B; Cai W; Huang Z
Scand J Immunol; 2017 Jun; 85(6):406-416. PubMed ID: 28349581
[TBL] [Abstract][Full Text] [Related]
42. Inhibitory effects of autoimmune disease by green tea in MRL-Faslprcg/Faslprcg mice.
Sayama K; Oguni I; Tsubura A; Tanaka S; Matsuzawa A
In Vivo; 2003; 17(6):545-52. PubMed ID: 14758719
[TBL] [Abstract][Full Text] [Related]
43. [The model of the two-hit of Knudson applies to the auto-immune diseases: the example of the lymphoproliferative syndrome with auto-immunity].
Magerus-Chatinet A; Rieux-Laucat F
Med Sci (Paris); 2011 Jan; 27(1):107-9. PubMed ID: 21299971
[No Abstract] [Full Text] [Related]
44. Identical phenotype in patients with somatic and germline CD95 mutations requires a new diagnostic approach to autoimmune lymphoproliferative syndrome.
Rössler J; Enders A; Lahr G; Heitger A; Winkler K; Fuchs H; Kopp M; Niemeyer C; Ehl S
J Pediatr; 2005 Nov; 147(5):691-4. PubMed ID: 16291365
[TBL] [Abstract][Full Text] [Related]
45. Autoimmunity and increased c-myb transcription.
Mountz JD; Steinberg AD; Klinman DM; Smith HR; Mushinski JF
Science; 1984 Nov; 226(4678):1087-9. PubMed ID: 6494925
[TBL] [Abstract][Full Text] [Related]
46. In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-lpr/lpr mice.
Xu X; Blinder L; Shen J; Gong H; Finnegan A; Williams JW; Chong AS
J Immunol; 1997 Jul; 159(1):167-74. PubMed ID: 9200452
[TBL] [Abstract][Full Text] [Related]
47. Sympathetic abnormalities during autoimmune processes: potential relevance of noradrenaline-induced apoptosis.
Del Rey A; Kabiersch A; Petzoldt S; Besedovsky HO
Ann N Y Acad Sci; 2003 May; 992():158-67. PubMed ID: 12794055
[TBL] [Abstract][Full Text] [Related]
48. Geoepidemiology and autoimmune manifestations of lymphoproliferative disorders.
Sands J; Tuscano JM
Autoimmun Rev; 2010 Mar; 9(5):A335-41. PubMed ID: 19914405
[TBL] [Abstract][Full Text] [Related]
49. Autoimmunity and lymphoproliferation: two genes are worse than one.
Cohen PL
Mol Interv; 2002 Nov; 2(7):427-30. PubMed ID: 14993405
[No Abstract] [Full Text] [Related]
50. Phosphatase PP2A is requisite for the function of regulatory T cells.
Apostolidis SA; Rodríguez-Rodríguez N; Suárez-Fueyo A; Dioufa N; Ozcan E; Crispín JC; Tsokos MG; Tsokos GC
Nat Immunol; 2016 May; 17(5):556-64. PubMed ID: 26974206
[TBL] [Abstract][Full Text] [Related]
51. Factors contributing to autoimmune disease.
Garza KM; Nguyen LT; Jones RG; Ohashi PS
Adv Exp Med Biol; 2001; 490():7-19. PubMed ID: 11505977
[No Abstract] [Full Text] [Related]
52. Autoimmune lymphoproliferative syndrome: types I, II and beyond.
Chun HJ; Lenardo MJ
Adv Exp Med Biol; 2001; 490():49-57. PubMed ID: 11505974
[No Abstract] [Full Text] [Related]
53. The AKT axis as a therapeutic target in autoimmune diseases.
Wu T; Mohan C
Endocr Metab Immune Disord Drug Targets; 2009 Jun; 9(2):145-50. PubMed ID: 19519464
[TBL] [Abstract][Full Text] [Related]
54. The autoimmune lymphoproliferative syndrome. A disorder of human lymphocyte apoptosis.
Fleisher TA; Puck JM; Strober W; Dale JK; Lenardo MJ; Siegel RM; Straus SE; Bleesing JJ
Clin Rev Allergy Immunol; 2001 Feb; 20(1):109-20. PubMed ID: 11269222
[No Abstract] [Full Text] [Related]
55. Somatic mutations--not just for cancer anymore.
Puck JM; Straus SE
N Engl J Med; 2004 Sep; 351(14):1388-90. PubMed ID: 15459299
[No Abstract] [Full Text] [Related]
56. Autoimmune lymphoproliferative syndrome.
Fleisher TA; Oliveira JB
Isr Med Assoc J; 2005 Dec; 7(12):758-61. PubMed ID: 16382694
[No Abstract] [Full Text] [Related]
57. Genetic disorders of programmed cell death in the immune system.
Bidère N; Su HC; Lenardo MJ
Annu Rev Immunol; 2006; 24():321-52. PubMed ID: 16551252
[TBL] [Abstract][Full Text] [Related]
58. Autoimmune lymphoproliferative syndrome: etiology, diagnosis, and management.
van der Werff ten Bosch J
Paediatr Drugs; 2003; 5(3):185-93. PubMed ID: 12608883
[TBL] [Abstract][Full Text] [Related]
59. Autoimmune lymphoproliferative syndrome: a cause of chronic splenomegaly, lymphadenopathy, and cytopenias in children-report on diagnosis and management of five patients.
Alvarado CS; Straus SE; Li S; Dale JK; Mann K; Le A; Lauer SJ
Pediatr Blood Cancer; 2004 Aug; 43(2):164-9. PubMed ID: 15236285
[TBL] [Abstract][Full Text] [Related]
60. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes.
Xiao C; Srinivasan L; Calado DP; Patterson HC; Zhang B; Wang J; Henderson JM; Kutok JL; Rajewsky K
Nat Immunol; 2008 Apr; 9(4):405-14. PubMed ID: 18327259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
